Cargando…
Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in sto...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458270/ https://www.ncbi.nlm.nih.gov/pubmed/26089872 http://dx.doi.org/10.1155/2015/578527 |
_version_ | 1782375063231660032 |
---|---|
author | Buderus, Stephan Boone, James H. Lentze, Michael J. |
author_facet | Buderus, Stephan Boone, James H. Lentze, Michael J. |
author_sort | Buderus, Stephan |
collection | PubMed |
description | Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in stool specimens collected prior to endoscopy for IBD (IBD-SCAN; TechLab, Blacksburg; normal < 7.3 µg/g feces). CRP was detected in serum (normal < 5 mg/L). Three patient groups were determined: n = 21 (mean age 13.2) with Crohn's disease (CD), n = 15 (mean age 10.9) with ulcerative colitis (UC), and n = 20 (mean age 11.9) in whom IBD was ruled out. In CD patients the endoscopic severity score SES-CD was correlated with the FL levels. Results. (Mean ± SEM). CRP levels were 27.18 ± 4.2 for CD-cases, 20.8 ± 9.5 for UC, and 0.24 ± 0.06 for non-IBD patients. FL levels were 313.6 ± 46.4 in CD, 370.7 ± 46.9 in UC, and 1.3 ± 0.5 in non-IBD patients. Sensitivity of CRP to detect IBD was 75% with specificity of 100%, positive predictive value of 100%, and negative predictive value of 69%. Sensitivity of FL was 100% with specificity of 95%, positive predictive value of 97.3%, and negative predictive value of 100%. In CD, FL levels correlated positively (R (2) = 0.42) with disease severity as judged by the SES-CD. Conclusions. Elevated FL corresponds to intestinal inflammation, even in patients with normal CRP. With high probability, normal FL excludes intestinal inflammation. |
format | Online Article Text |
id | pubmed-4458270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44582702015-06-18 Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD Buderus, Stephan Boone, James H. Lentze, Michael J. Gastroenterol Res Pract Clinical Study Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in stool specimens collected prior to endoscopy for IBD (IBD-SCAN; TechLab, Blacksburg; normal < 7.3 µg/g feces). CRP was detected in serum (normal < 5 mg/L). Three patient groups were determined: n = 21 (mean age 13.2) with Crohn's disease (CD), n = 15 (mean age 10.9) with ulcerative colitis (UC), and n = 20 (mean age 11.9) in whom IBD was ruled out. In CD patients the endoscopic severity score SES-CD was correlated with the FL levels. Results. (Mean ± SEM). CRP levels were 27.18 ± 4.2 for CD-cases, 20.8 ± 9.5 for UC, and 0.24 ± 0.06 for non-IBD patients. FL levels were 313.6 ± 46.4 in CD, 370.7 ± 46.9 in UC, and 1.3 ± 0.5 in non-IBD patients. Sensitivity of CRP to detect IBD was 75% with specificity of 100%, positive predictive value of 100%, and negative predictive value of 69%. Sensitivity of FL was 100% with specificity of 95%, positive predictive value of 97.3%, and negative predictive value of 100%. In CD, FL levels correlated positively (R (2) = 0.42) with disease severity as judged by the SES-CD. Conclusions. Elevated FL corresponds to intestinal inflammation, even in patients with normal CRP. With high probability, normal FL excludes intestinal inflammation. Hindawi Publishing Corporation 2015 2015-05-24 /pmc/articles/PMC4458270/ /pubmed/26089872 http://dx.doi.org/10.1155/2015/578527 Text en Copyright © 2015 Stephan Buderus et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Buderus, Stephan Boone, James H. Lentze, Michael J. Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title | Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title_full | Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title_fullStr | Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title_full_unstemmed | Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title_short | Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD |
title_sort | fecal lactoferrin: reliable biomarker for intestinal inflammation in pediatric ibd |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458270/ https://www.ncbi.nlm.nih.gov/pubmed/26089872 http://dx.doi.org/10.1155/2015/578527 |
work_keys_str_mv | AT buderusstephan fecallactoferrinreliablebiomarkerforintestinalinflammationinpediatricibd AT boonejamesh fecallactoferrinreliablebiomarkerforintestinalinflammationinpediatricibd AT lentzemichaelj fecallactoferrinreliablebiomarkerforintestinalinflammationinpediatricibd |